Rheumatology Medical News about systemic sclerosis angiogenesis;high amounts of vascular endothelial growth factor

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis
Rheumatology, 06/25/09

Solanilla A et al. – Study demonstrates that platelets transport high levels of VEGF in systemic sclerosis (SSc); may contribute to circulating VEGF because of ongoing activation in the course of the disease. If activated at the contact of injured endothelium, platelets may be important in the altered angiogenesis.

Methods

An investigation of platelet activation and the role of platelets as a source of VEGF and other angiogenic mediators in SSc
40 patients with SSc; age- and sex-matched healthy subjects and subjects presenting a primary RP as controls
Platelets were isolated, activated with thrombin and the secretion of VEGF, PDGF, homodimeric form BB (PDGF-BB), TGF-β1 and angiopoietins-1 and -2 measured
Plasma concns of these mediators and the functionality of platelet-derived VEGF were also studied
Platelet activation was assayed by measuring plasma β-thromboglobulin and expression of P-selectin on platelets
The effect of iloprost on VEGF secretion by platelets was studied

Results

Platelets from SSc pts, vs controls, secreted large amounts of VEGF when activated, but not PDGF-BB, TGF-β1 or angiopoietins
Increased expression of membrane P-selectin confirmed platelet activation in the pts
Iloprost inhibited VEGF secretion by platelets both in vivo and in vitro, through inhibition of platelet activation

<< Previous
Ultrasonography shows disappearance of monosodium urate crystal...

Next >>
Prevention of vertebral fractures in osteoporosis: Mixed...